Depression and Anxiety Trial, Recruiting NCT07388004 Sponsor: Philipps University Marburg Condition: Depression and Anxiety
Back to Depression And Anxiety

Depression and Anxiety Trial, Recruiting

NCT07388004
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged between 18 and 80 years
  • People who have been diagnosed with major depressive disorder (a form of clinical depression) according to standard diagnostic guidelines, confirmed through a structured clinical interview
  • People whose depression symptoms score at or above a certain level on a standard rating scale called the HAMD-21 (confirm with trial site)
  • People who are able to attend group therapy sessions twice a week for five weeks
  • People who are able to have an MRI brain scan, if taking part in the brain imaging part of the study
  • People who have given written agreement to take part in the study

Who may not be able to join:

  • People who have ever been diagnosed with bipolar disorder, a psychotic disorder, or a primary substance use disorder
  • People who are currently considered to be at high acute risk of suicide requiring immediate intervention
  • People who have a serious neurological condition, a brain injury, or any reason they cannot safely have an MRI scan (such as metal implants in the body or severe claustrophobia)
  • People who are currently receiving psychotherapy, or who have started a new antidepressant medication within the past four weeks
  • People who do not have sufficient proficiency in the German language to take part in therapy sessions and complete the study assessments
  • People who have cognitive impairment or other conditions that would affect their ability to give informed consent or participate fully in the study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Winfried Rief, Prof. Dr., Philipps University Marburg

Phone: +4917656538480

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Philipps University Marburg
Registry
ClinicalTrials.gov
Start date
13 October 2025
Est. completion
31 December 2027

Where this trial is recruiting

🇩🇪 Germany

Primary endpoints

Change in Depressive Symptoms (Beck Depression Inventory-II)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov